Return On Assets of Revance Therapeutics, Inc. from 30 Sep 2014 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Revance Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2014 to 30 Sep 2024.
  • Revance Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2024 was -38%, a 48% increase year-over-year.
  • Revance Therapeutics, Inc. annual Return On Assets for 2023 was -60%, a 5.2% decline from 2022.
  • Revance Therapeutics, Inc. annual Return On Assets for 2022 was -57%, a 23% decline from 2021.
  • Revance Therapeutics, Inc. annual Return On Assets for 2021 was -46%, a 6.8% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Revance Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -38% +35% +48% 01 Jul 2024 30 Sep 2024
Q2 2024 -57% +2% +2.7% 01 Apr 2024 30 Jun 2024
Q1 2024 -60% -1% -2.4% 01 Jan 2024 31 Mar 2024
Q4 2023 -60% -3% -5.2% 01 Oct 2023 31 Dec 2023
Q3 2023 -73% -29% -64% 01 Jul 2023 30 Sep 2023
Q2 2023 -59% -13% -29% 01 Apr 2023 30 Jun 2023
Q1 2023 -59% -13% -28% 01 Jan 2023 31 Mar 2023
Q4 2022 -57% -11% -23% 01 Oct 2022 31 Dec 2022
Q3 2022 -45% +1% +1.1% 01 Jul 2022 30 Sep 2022
Q2 2022 -46% -1% -3.1% 01 Apr 2022 30 Jun 2022
Q1 2022 -46% -2% -5.3% 01 Jan 2022 31 Mar 2022
Q4 2021 -46% -3% -6.8% 01 Oct 2021 31 Dec 2021
Q3 2021 -45% 0% -0.98% 01 Jul 2021 30 Sep 2021
Q2 2021 -44% +3% +6.4% 01 Apr 2021 30 Jun 2021
Q1 2021 -43% +6% +13% 01 Jan 2021 31 Mar 2021
Q4 2020 -43% +9% +17% 01 Oct 2020 31 Dec 2020
Q3 2020 -45% +11% +19% 01 Jul 2020 30 Sep 2020
Q2 2020 -47% +7% +13% 01 Apr 2020 30 Jun 2020
Q1 2020 -50% +5% +9.1% 01 Jan 2020 31 Mar 2020
Q4 2019 -52% +5% +8.5% 01 Oct 2019 31 Dec 2019
Q3 2019 -56% -2% -4.6% 01 Jul 2019 30 Sep 2019
Q2 2019 -54% +2% +2.7% 01 Apr 2019 30 Jun 2019
Q1 2019 -55% +2% +3.7% 01 Jan 2019 31 Mar 2019
Q4 2018 -57% +1% +2.3% 01 Oct 2018 31 Dec 2018
Q3 2018 -53% +5% +8.2% 01 Jul 2018 30 Sep 2018
Q2 2018 -56% -8% -17% 01 Apr 2018 30 Jun 2018
Q1 2018 -57% -13% -29% 01 Jan 2018 31 Mar 2018
Q4 2017 -58% -20% -51% 01 Oct 2017 31 Dec 2017
Q3 2017 -58% -24% -71% 01 Jul 2017 30 Sep 2017
Q2 2017 -48% -11% -30% 01 Apr 2017 30 Jun 2017
Q1 2017 -44% -8% -23% 01 Jan 2017 31 Mar 2017
Q4 2016 -39% -1% -3.3% 01 Oct 2016 31 Dec 2016
Q3 2016 -34% +3% +9% 01 Jul 2016 30 Sep 2016
Q2 2016 -37% -4% -13% 01 Apr 2016 30 Jun 2016
Q1 2016 -36% -7% -26% 01 Jan 2016 31 Mar 2016
Q4 2015 -37% -3% -8.4% 01 Oct 2015 31 Dec 2015
Q3 2015 -37% +5% +11% 01 Jul 2015 30 Sep 2015
Q2 2015 -32% 01 Apr 2015 30 Jun 2015
Q1 2015 -28% 01 Jan 2015 31 Mar 2015
Q4 2014 -34% 01 Oct 2014 31 Dec 2014
Q3 2014 -42% 01 Jul 2014 30 Sep 2014

Revance Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -60% -3% -5.2% 01 Jan 2023 31 Dec 2023
2022 -57% -11% -23% 01 Jan 2022 31 Dec 2022
2021 -46% -3% -6.8% 01 Jan 2021 31 Dec 2021
2020 -43% +9% +17% 01 Jan 2020 31 Dec 2020
2019 -52% +5% +8.5% 01 Jan 2019 31 Dec 2019
2018 -57% -1% -1.5% 01 Jan 2018 31 Dec 2018
2017 -56% -17% -45% 01 Jan 2017 31 Dec 2017
2016 -39% -1% -3.3% 01 Jan 2016 31 Dec 2016
2015 -37% -3% -8.4% 01 Jan 2015 31 Dec 2015
2014 -34% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.